Henderson John T. - 15 Apr 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Apr 2025, 16:25:13 UTC
Prior SEC filing
06 Jan 2025
Next SEC filing
14 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Henderson

Key filing fact

Henderson John T. filed Form 4 for CYTOKINETICS INC (CYTK) on 16 Apr 2025.

Key facts

  • This page summarizes Henderson John T.'s Form 4 filing for CYTOKINETICS INC (CYTK).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 16 Apr 2025, 16:25.

Change

  • Previous filing in this sequence was filed on 06 Jan 2025.
  • Current net transaction value: +$875.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CYTK transaction

Common Stock

Options Exercise

Transaction value
$124,200
Shares
+20,000
Change %
+40%
Price
$6.21
Shares after
69,538
Date
15 Apr 2025
Ownership
Direct
CYTK transaction

Common Stock

Sale

Transaction value
$123,325
Shares
-3,190
Change %
-4.6%
Price
$38.66
Shares after
66,348
Date
15 Apr 2025
Ownership
Direct
CYTK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
83
Date
15 Apr 2025
Ownership
by Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CYTK transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-20,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
15 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$6.21
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .